GRN Holding Corporation

GRN Holding Corporation

GRNF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.37M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
GRN Holding CorporationGRN Holding Corporation0.5--4%--
$0.00

Current Fair Value

0% upside

Overvalued by 0% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$1.37 Million
Enterprise Value$1.37 Million
Earnings per Share$0
Beta-1.33
Outstanding Shares25,342,146

Return

Return on Equity-3.99%ROE
Return on Assets-3.83%
Return on Invested Capital-3.98%

Valuation & Multiples

P/E Ratio0.54P/E Ratio
PEG-0.6PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue40.39
Enterprise Value to EBIT-26.26
Enterprise Value to Net Income-27
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Nextel Medical Corp.

1 employees
CEO: Donald J. Steinberg

Nextel Medical Corp., a clinical stage biotechnology company, develops ways to exploit the therapeutic potential of exosomes for the field of oncology in the United States. The company was formerly known as Exousia Pro, Inc. and changed ...